Profile of abemaciclib and its potential in the treatment of breast cancer
Sign Up to like & getrecommendations! Published in 2018 at "OncoTargets and therapy"
DOI: 10.2147/ott.s149245
Abstract: Hormone-receptor-positive breast cancer is the most common subtype of breast cancer among patients with both early-stage and metastatic disease. Recent advances in the understanding of its pathophysiology have led to the discovery and utilization of… read more here.
Keywords: profile abemaciclib; treatment breast; breast; breast cancer ... See more keywords